[Not Available]

Area of Science:

• Gynecologic Oncology
• Surgical Oncology

Context:

• Uterine cancer, including cervical and endometrial types, can metastasize to pelvic and para-aortic lymph nodes.
• Lymphadenectomy is standard for early cervical cancer but its therapeutic role is debated for other uterine cancers.

Purpose:

• To review the diagnostic, prognostic, and therapeutic value of lymphadenectomy in uterine cancers.
• To discuss the role of lymphadenectomy in early-stage cervical cancer and its extension to the para-aortic region.
• To evaluate the complexities of lymphadenectomy in endometrial cancer given patient co-morbidities.

Summary:

• Pelvic lymphadenectomy is routine in radical hysterectomy for early cervical cancer (<4 cm).
• Para-aortic lymph node dissection may be considered if pelvic nodes are involved; sentinel lymph node studies are ongoing.
• For larger cervical cancers (>4 cm), radiotherapy is standard, with pre-radiation laparoscopy aiding in defining radiation fields based on lymph node status.
• The benefit of lymphadenectomy in endometrial cancer is less clear due to increased surgical risks associated with patient co-morbidities.

Impact:

• Clarifies the established and debated roles of lymphadenectomy in uterine cancer management.
• Highlights the importance of staging and risk stratification in surgical decision-making for gynecologic malignancies.
• Informs clinical practice regarding the extent of lymph node assessment and dissection in cervical and endometrial cancers.